339 related articles for article (PubMed ID: 15784029)
1. Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging.
Olynyk JK; St Pierre TG; Britton RS; Brunt EM; Bacon BR
Am J Gastroenterol; 2005 Apr; 100(4):837-41. PubMed ID: 15784029
[TBL] [Abstract][Full Text] [Related]
2. Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis.
Crawford DH; Murphy TL; Ramm LE; Fletcher LM; Clouston AD; Anderson GJ; Subramaniam VN; Powell LW; Ramm GA
Hepatology; 2009 Feb; 49(2):418-25. PubMed ID: 19177571
[TBL] [Abstract][Full Text] [Related]
3. Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis.
Chin J; Powell LW; Ramm LE; Ayonrinde OT; Ramm GA; Olynyk JK
Sci Rep; 2019 Dec; 9(1):20234. PubMed ID: 31882912
[TBL] [Abstract][Full Text] [Related]
4. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
[TBL] [Abstract][Full Text] [Related]
5. Serum ferritin concentration predicts hepatic fibrosis better than hepatic iron concentration in human HFE-Haemochromatosis.
Wood MJ; Crawford DHG; Wockner LF; Powell LW; Ramm GA
Liver Int; 2017 Sep; 37(9):1382-1388. PubMed ID: 28231420
[TBL] [Abstract][Full Text] [Related]
6. [Utility of various non-invasive methods for fibrosis prediction among Basque Country patients with phenotypic hemochromatosis].
Castiella A; Zapata E; Otazua P; Fernández J; Alustiza JM; Ugarte M; Legasa L; Galardi A; Ugalde A; Barredo I; Arriola JA
Rev Esp Enferm Dig; 2008 Oct; 100(10):611-4. PubMed ID: 19119785
[TBL] [Abstract][Full Text] [Related]
7. Clinical cofactors and hepatic fibrosis in hereditary hemochromatosis: the role of diabetes mellitus.
Wood MJ; Powell LW; Dixon JL; Ramm GA
Hepatology; 2012 Sep; 56(3):904-11. PubMed ID: 22422567
[TBL] [Abstract][Full Text] [Related]
8. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
[TBL] [Abstract][Full Text] [Related]
9. Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general population.
Aleman S; Endalib S; Stål P; Lööf L; Lindgren S; Sandberg-Gertzén H; Almer S; Olsson S; Danielsson A; Wallerstedt S; Hultcrantz R
Scand J Gastroenterol; 2011 Sep; 46(9):1118-26. PubMed ID: 21675821
[TBL] [Abstract][Full Text] [Related]
10. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
[TBL] [Abstract][Full Text] [Related]
11. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
[TBL] [Abstract][Full Text] [Related]
12. Screening for hemochromatosis in asymptomatic subjects with or without a family history.
Powell LW; Dixon JL; Ramm GA; Purdie DM; Lincoln DJ; Anderson GJ; Subramaniam VN; Hewett DG; Searle JW; Fletcher LM; Crawford DH; Rodgers H; Allen KJ; Cavanaugh JA; Bassett ML
Arch Intern Med; 2006 Feb; 166(3):294-301. PubMed ID: 16476869
[TBL] [Abstract][Full Text] [Related]
13. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
[TBL] [Abstract][Full Text] [Related]
14. Steatosis is a cofactor in liver injury in hemochromatosis.
Powell EE; Ali A; Clouston AD; Dixon JL; Lincoln DJ; Purdie DM; Fletcher LM; Powell LW; Jonsson JR
Gastroenterology; 2005 Dec; 129(6):1937-43. PubMed ID: 16344062
[TBL] [Abstract][Full Text] [Related]
15. Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques.
Bonkovsky HL; Rubin RB; Cable EE; Davidoff A; Rijcken TH; Stark DD
Radiology; 1999 Jul; 212(1):227-34. PubMed ID: 10405746
[TBL] [Abstract][Full Text] [Related]
16. Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
[TBL] [Abstract][Full Text] [Related]
17. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.
Smith BC; Gorve J; Guzail MA; Day CP; Daly AK; Burt AD; Bassendine MF
Hepatology; 1998 Jun; 27(6):1695-9. PubMed ID: 9620344
[TBL] [Abstract][Full Text] [Related]
18. Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing.
Nash S; Marconi S; Sikorska K; Naeem R; Nash G
Am J Clin Pathol; 2002 Jul; 118(1):73-81. PubMed ID: 12109859
[TBL] [Abstract][Full Text] [Related]
19. Ductular reaction in hereditary hemochromatosis: the link between hepatocyte senescence and fibrosis progression.
Wood MJ; Gadd VL; Powell LW; Ramm GA; Clouston AD
Hepatology; 2014 Mar; 59(3):848-57. PubMed ID: 24037895
[TBL] [Abstract][Full Text] [Related]
20. The role of iron in nonalcoholic fatty liver disease: the story continues.
Kowdley KV
Gastroenterology; 2010 Mar; 138(3):817-9. PubMed ID: 20116466
[No Abstract] [Full Text] [Related]
[Next] [New Search]
